Published in Clin Exp Immunol on January 01, 2001
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol (2005) 1.51
A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep (2017) 1.40
The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol (2010) 0.96
T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine. Clin Diagn Lab Immunol (2003) 0.96
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? World J Gastroenterol (2010) 0.91
Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation. Front Immunol (2013) 0.82
A method for high purity intestinal epithelial cell culture from adult human and murine tissues for the investigation of innate immune function. J Immunol Methods (2014) 0.80
Inflammatory bowel diseases influence major histocompatibility complex class I (MHC I) and II compartments in intestinal epithelial cells. Clin Exp Immunol (2013) 0.80
Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules. J Biol Chem (2015) 0.78
Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells. Clin Exp Immunol (2002) 0.78
Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats. Oxid Med Cell Longev (2016) 0.75
Decreased CD8+CD28+/CD8+CD28- T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease. Medicine (Baltimore) (2017) 0.75
Anti-NKG2D mAb: A New Treatment for Crohn's Disease? Int J Mol Sci (2017) 0.75
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology (1976) 15.65
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest (1995) 7.68
Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest (1989) 4.28
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ (1989) 4.13
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med (1996) 3.82
Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med (1987) 3.53
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology (1997) 3.00
In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells. J Exp Med (1963) 2.95
The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci (1992) 2.58
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol (1997) 2.55
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today (1997) 2.52
Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology (1986) 2.32
Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology (1995) 2.07
Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. Immunology (1986) 1.75
Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology (1992) 1.53
A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis. Biochem J (1991) 1.37
Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J Clin Immunol (1997) 1.36
Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J Cell Physiol (1991) 1.36
Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest (1990) 1.35
CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med (1993) 1.31
Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation. J Immunol Methods (1992) 1.28
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes. J Immunol (1998) 1.24
Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol (1996) 1.21
T cell-monocyte interactions regulate epithelial physiology in a coculture model of inflammation. Am J Physiol (1996) 1.19
Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol (1998) 1.18
Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J Exp Med (1994) 1.14
Mucosal immunology: new frontiers. Immunol Today (1996) 1.10
Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut (1992) 1.03
Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol (1996) 1.02
Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56lck. J Exp Med (1995) 1.02
Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest (1997) 1.02
IFN-gamma modulates CD1d surface expression on intestinal epithelia. Am J Physiol (1996) 0.99
The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol (1997) 0.96
Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC). Clin Exp Immunol (1998) 0.88
Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: evaluation of an in vitro model. Eur J Clin Invest (1995) 0.86
Pitfalls in the characterization of small intestinal lymphocytes. J Immunol Methods (1995) 0.77
Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest (2000) 3.47
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology (2001) 2.69
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Complications of double balloon enteroscopy: a multicenter survey. Endoscopy (2007) 2.28
Gastric inhibitory action of H2-antagonists ranitidine and cimetidine. Lancet (1979) 2.01
Carbon dioxide insufflation improves intubation depth in double-balloon enteroscopy: a randomized, controlled, double-blind trial. Endoscopy (2007) 1.98
Spontaneous flow of bile through the human pancreatic duct in the absence of pancreatitis: nature's human experiment. Endoscopy (2003) 1.95
Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology (1980) 1.93
Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology (2001) 1.86
T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut (1997) 1.79
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol (2001) 1.67
Single- vs. double-balloon enteroscopy in small-bowel diagnostics: a randomized multicenter trial. Endoscopy (2011) 1.59
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy (1999) 1.51
Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci (1998) 1.46
Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol (2000) 1.44
Mechanical lithotripsy of bile duct stones in 209 patients--effect of technical advances. Endoscopy (1988) 1.39
Cholangiofibromatosis associated with portal hypertension. Am J Gastroenterol (1994) 1.39
[Surgical procedure in Crohn disease]. Chirurg (1992) 1.38
Effects of 13-nle-motilin in man--inhibition of gastric evacuation and stimulation of pepsin secretion. Scand J Gastroenterol (1975) 1.35
Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography. Scand J Gastroenterol (2000) 1.31
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
New histamine H2-receptor antagonists. Hepatogastroenterology (1980) 1.30
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1995) 1.30
In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol (1998) 1.28
Differential responsiveness to CD3-Ti vs. CD2-dependent activation of human intestinal T lymphocytes. Eur J Immunol (1990) 1.25
Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology (1991) 1.25
Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion (1995) 1.25
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Risks of intestinal anastomoses in Crohn's disease. Ann Surg (1991) 1.20
Plasma secretin and pancreatic bicarbonate response to exogenous secretin in man. Gut (1977) 1.19
Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology (2001) 1.19
Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut (2004) 1.17
Motilin-induced electrical activity in the canine gastrointestinal tract. Scand J Gastroenterol Suppl (1976) 1.15
Tumors of the papilla of Vater--inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol (1999) 1.15
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut (1994) 1.13
Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology (1975) 1.11
Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst (1999) 1.11
[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]. Z Gastroenterol (2011) 1.11
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy (2002) 1.10
Release of motilin after duodenal acidification. Lancet (1976) 1.10
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut (1978) 1.09
Exocrine pancreatic function in juvenile diabetics. Am J Dig Dis (1975) 1.08
[Piezoelectric lithotripsy of gallstones. Initial clinical experiences]. Dtsch Med Wochenschr (1988) 1.08
Gastric duplication cyst: a rare endosonographic finding in an adult. Scand J Gastroenterol (2005) 1.08
Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT--a prospective, histopathologically controlled study. Gastrointest Endosc (1999) 1.07
Role of appendix and spleen in experimental colitis. J Surg Res (2001) 1.07
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.06
Tissue reactions under piezoelectric shockwave application for the fragmentation of biliary calculi. Gut (1989) 1.06
Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut (2006) 1.06
CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia. J Biol Chem (2001) 1.05
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin. Gastroenterology (1976) 1.05
Cogan's syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol (2001) 1.05
The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg (1996) 1.04
Pharmacokinetics of motilin in man. Gastroenterology (1977) 1.03
The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest (1995) 1.03
Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol (1996) 1.02
Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol (2005) 1.02
Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut (2002) 1.02
Role of M cells in intestinal barrier function. Ann N Y Acad Sci (2000) 1.01
Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin Exp Immunol (2010) 1.00
Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch (1995) 1.00
Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol (1999) 0.99
IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol (1998) 0.99
Biliary stent occlusion--a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy (1992) 0.99
CCR6 identifies lymphoid tissue inducer cells within cryptopatches. Clin Exp Immunol (2010) 0.98
Standardized grey scale ultrasonography in Graves' disease: correlation to autoimmune activity. Eur J Endocrinol (1999) 0.98
Effect of 13-Nle-motilin on small intestinal transit time in healthy subjects. Scand J Gastroenterol Suppl (1976) 0.98
Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis (2001) 0.98
Human intestinal mucosa alters T-cell reactivities. Gastroenterology (1993) 0.98
Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol (1997) 0.97
Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther (2001) 0.97
Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers Z Physiol Chem (1971) 0.96
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol (1994) 0.96
Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol (2006) 0.96
Influence of enkephalin on K+-evoked efflux of putative neurotransmitters in rat brain. Selective inhibition of acetylcholine and dopamine release. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.96
SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet (2003) 0.95